Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Sarcoma × Aminolevulinic Acid × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Sarcoma 1 Mycosis Fungoides 1 Glioblastoma 1 Carcinoma, Basal Cell 1

Interventions

pembrolizumab 3 Oncolytic Virotherapy 3 Magnetic Resonance Spectroscopy 3 Specimen Handling 2 Radiotherapy 2 Nivolumab 2 Irinotecan 2 Doxorubicin 2 Cyclophosphamide 2 trastuzumab biosimilar HLX02 1 sodium thiosulfate 1 pertuzumab 1 perflutren 1 palbociclib 1 olaparib 1 niraparib 1 montelukast 1 eribulin 1 entrectinib 1 cobimetinib 1 camrelizumab 1 atezolizumab 1 apatinib 1 alovudine 1 alectinib 1 X-Rays 1 Vinorelbine 1 Vincristine 1 Vemurafenib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡